OTCMKTS:CHEOY Cochlear (CHEOY) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CHEOY Stock Alerts $105.17 +2.52 (+2.45%) (As of 04/26/2024 08:54 PM ET) Add Compare Share Share Today's Range$104.38▼$105.1750-Day Range$100.90▼$114.5052-Week Range$73.73▼$114.50Volume3,000 shsAverage Volume3,365 shsMarket Capitalization$13.78 billionP/E RatioN/ADividend Yield1.10%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort Interest Get Cochlear alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Cochlear Stock (OTCMKTS:CHEOY)Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More CHEOY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEOY Stock News HeadlinesApril 27, 2024 | finance.yahoo.comCochlear (ASX:COH) May Have Issues Allocating Its CapitalApril 3, 2024 | marketwatch.comCochlear's Oticon Implants Acquisition Approved by Australian RegulatorApril 29, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… March 27, 2024 | afr.comCan a vaccine slow down the Cochlear train?March 20, 2024 | finance.yahoo.comCochlear Ltd's Dividend AnalysisFebruary 28, 2024 | prnewswire.comCochlear calls for action in Washington D.C. ahead of World Hearing DayFebruary 25, 2024 | msn.comCochlear Limited - Depositary Receipt () (CHEOY) Price Target Increased by 11.05% to 94.91February 22, 2024 | prnewswire.comCochlear announces 2024 winners of annual scholarshipsApril 29, 2024 | InvestorPlace (Ad)Have You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...February 19, 2024 | realmoney.thestreet.comCochlear price target raised by A$20 at UBS, here's whyFebruary 19, 2024 | realmoney.thestreet.comCochlear price target raised by A$18 at Morgan Stanley, here's whyFebruary 19, 2024 | afr.comWhat we learnt from Cochlear, Wesptac, Ampol and Bendigo’s resultsFebruary 18, 2024 | markets.businessinsider.comCiti Reaffirms Their Sell Rating on Cochlear Limited (CHEOF)February 18, 2024 | msn.comCochlear's first-half profit up 35pct to $191 millionFebruary 18, 2024 | fool.com.auCochlear share price falls despite 29% dividend boostFebruary 18, 2024 | marketwatch.comCochlear Hoists Dividend on 35% Jump in 1H Profit -- UpdateFebruary 18, 2024 | afr.comCochlear’s big first half delivers best dividend in a decadeFebruary 16, 2024 | finance.yahoo.comCochlear Implant Market to Accumulate a Valuation of USD 4.0 Billion by 2030, Advancing at a 10.36% CAGR | MarketDigitsFebruary 12, 2024 | markets.businessinsider.comMorgans downgrades Cochlear Limited (CHEOF) to a HoldFebruary 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: CSL (CMXHF), Cochlear Limited (CHEOF)February 8, 2024 | afr.comCochlear lifts guidance despite threat of deafness drugsFebruary 7, 2024 | fool.com.auCochlear shares jump 6% on guidance upgradeFebruary 7, 2024 | marketwatch.comCochlear Shares Jump Amid Stronger-Than-Expected Implant SalesFebruary 6, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Incyte (INCY) and Cochlear Limited (OtherCHEOF)January 25, 2024 | finance.yahoo.comGlobal Cochlear Implants Market Report 2024: Market Forecast for 5 Regions and 17+ Countries, Company Profiles of the Top 10+ Major Market PlayersNovember 27, 2023 | msn.comCochlear - ADR (CHEOY) Price Target Increased by 5.45% to 83.47November 8, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED) and Cochlear Limited (OtherCHEOF)See More Headlines Receive CHEOY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/30 Dividend3/21/2024Today4/29/2024Dividend Payable4/30/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:CHEOY Previous SymbolOTCMKTS:CHEOY CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio2.57 Quick Ratio1.94 Sales & Book Value Annual Sales$1.32 billion Price / Sales10.46 Cash Flow$1.98 per share Price / Cash Flow53.13 Book Value$8.97 per share Price / Book11.72Miscellaneous Outstanding Shares130,990,000Free FloatN/AMarket Cap$13.78 billion OptionableNot Optionable Beta0.91 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 57)MBA, CEO, MD, President & Executive Director Comp: $3.11MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 59)Chief Technology Officer Comp: $1.33MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVice President of Investor RelationsMs. Jennifer StevensonVP of Corporate Communications & BrandMr. Dean PhizackleaSenior Vice President of Global Strategic MarketingMs. Jennifer HornerySenior Vice President of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Senior Vice President of Global Supply ChainMr. Anthony BishopPresident of Asia Pacific & Latin AmericaMore ExecutivesKey CompetitorsViatrisNASDAQ:VTRSNeurocrine BiosciencesNASDAQ:NBIXBeiGeneNASDAQ:BGNESandoz GroupOTCMKTS:SDZNYShionogi & Co., Ltd.OTCMKTS:SGIOYView All Competitors CHEOY Stock Analysis - Frequently Asked Questions Should I buy or sell Cochlear stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cochlear in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CHEOY shares. View CHEOY analyst ratings or view top-rated stocks. How have CHEOY shares performed in 2024? Cochlear's stock was trading at $101.39 at the beginning of the year. Since then, CHEOY shares have increased by 3.7% and is now trading at $105.17. View the best growth stocks for 2024 here. Are investors shorting Cochlear? Cochlear saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,200 shares, a drop of 42.9% from the March 31st total of 2,100 shares. Based on an average daily volume of 6,200 shares, the days-to-cover ratio is presently 0.2 days. View Cochlear's Short Interest. How often does Cochlear pay dividends? What is the dividend yield for Cochlear? Cochlear announced a dividend on Saturday, March 16th. Investors of record on Friday, March 22nd will be given a dividend of $0.0336 per share on Tuesday, April 30th. This represents a yield of 1%. The ex-dividend date of this dividend is Thursday, March 21st. Read our dividend analysis for CHEOY. Is Cochlear a good dividend stock? Cochlear (OTCMKTS:CHEOY) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.11%. Read our dividend analysis for CHEOY. How do I buy shares of Cochlear? Shares of CHEOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CHEOY) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
